Sabra Health Care REIT reported first quarter 2024 results, with net income of $0.11 per diluted common share, FFO of $0.32, Normalized FFO of $0.34, AFFO of $0.35, and Normalized AFFO of $0.35. The company reiterated its 2024 earnings guidance. Sabra's portfolio continues to grow stronger, with improvements in coverage, occupancy, and NOI.
Net Income: $0.11 per diluted common share
FFO: $0.32 per share
Normalized FFO: $0.34 per share
AFFO: $0.35 per share
Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): •Net Income: $0.53 - $0.57 •FFO: $1.33 - $1.37 •Normalized FFO: $1.34 - $1.38 •AFFO: $1.38 - $1.42 •Normalized AFFO: $1.39 - $1.43 Earnings guidance above assumes no 2024 acquisition or disposition activity.
Visualization of income flow from segment revenue to net income